Skip to main content
. 2022 Jul 20;9:868635. doi: 10.3389/fcvm.2022.868635

Table 3.

Summary of different hypertension telemedicine studies.

Study Study design Assessed device/technique Number of patients End-points Results
Wakefield et al. (39) Randomized, controlled trial−3 treatment groups (high intensity vs. low intensity vs. usual care) Home telehealth device (daily BP monitoring and differentiated questionnaire low vs. high intensity group) and nurse management 302 Primary outcome: SBP change Positive for the high intensity group
Hebert et al. (40) Randomized, controlled trial−3 arms (nurse management vs. home monitoring vs. usual care) Nurse counseling; Informing on strategies for controlling BP 416 Changes in SBP and DBP at 9 and 18 months Positive for SBP in the nurse counseling group
Pan et al. (41) Randomized, controlled trial−2 arms Home telemonitoring for blood pressure (delivered by a GP, a hypertension specialist, a nurse) 198 Change in SBP at 1, 3, and 6 months Positive
Margolis et al. (42) Randomized, controlled trial−2 arms Home BP monitoring and pharmacist management 450 Changes in SBP and DBP Positive (for up to 24 months)
McManus et al. (43) Randomized, controlled trial−3 arms (self-monitoring vs. telemonitoring vs. usual care) Self-monitoring with electronic sphygmomanometer vs. telemonitoring via phone messages 1,003 Change in SBP at 12 months Positive in both intervention groups
Mohsen et al. (44) Randomized, controlled trial – 2 arms Nurse counseling by follow-up phone calls 100 Changes in mean arterial pressure and body-mass index Positive